Gene · 2826
Papers2,000
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,000
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioinformatics analysis of GPS1 expression and biological function in breast cancer. | J Cancer Res Clin Oncol | 2024 | 38289496 | PubTator, text mining | PubMed |
| Investigation of Potential Drug Targets Involved in Inflammation Contributing to Alzheimer's Disease Progression. | Pharmaceuticals (Basel) | 2024 | 38276010 | PubTator, text mining | PubMed |
| Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit. | Cancers (Basel) | 2024 | 38254801 | PubTator, text mining | PubMed |
| Single-Cell Sequencing Combined with Transcriptome Sequencing Constructs a Predictive Model of Key Genes in Multiple Sclerosis and Explores Molecular Mechanisms Related to Cellular Communication. | J Inflamm Res | 2024 | 38226354 | PubTator, text mining | PubMed |
| Proinflammatory chemokine CXCL14 activates MAS-related G protein-coupled receptor MRGPRX2 and its putative mouse ortholog MRGPRB2. | Commun Biol | 2024 | 38184723 | PubTator, text mining | PubMed |
| A novel prognostic predictor of immune microenvironment and therapeutic response in clear cell renal cell carcinoma based on angiogenesis-immune-related gene signature. | Heliyon | 2024 | 38170124 | PubTator, text mining | PubMed |
| Bibliometric analysis and description of research trends on T cells in psoriasis over the past two decades (2003-2022). | Heliyon | 2024 | 38169994 | PubTator, text mining | PubMed |
| CC chemokine receptors are prognostic indicators of gastric cancer and are associated with immune infiltration. | BMC Med Genomics | 2024 | 38169378 | PubTator, text mining | PubMed |
| Characterization of Cell Type Abundance and Gene Expression Timeline from Burned Skin Bulk Transcriptomics by Deconvolution. | J Burn Care Res | 2024 | 37956340 | PubTator, text mining | PubMed |
| Blinatumomab consolidation post-autologous stem cell transplantation in patients with diffuse large B-cell lymphoma. | Blood Adv | 2024 | 37871306 | PubTator, text mining | PubMed |
| CLEC11A expression as a prognostic biomarker in correlation to immune cells of gastric cancer. | Biomol Biomed | 2024 | 37597212 | PubTator, text mining | PubMed |
| Targeting T-cell integrins in autoimmune and inflammatory diseases. | Clin Exp Immunol | 2024 | 37556361 | PubTator, text mining | PubMed |
| EPCR deficiency ameliorates inflammatory arthritis in mice by suppressing the activation and migration of T cells and dendritic cells. | Rheumatology (Oxford) | 2024 | 37228024 | PubTator, text mining | PubMed |
| Short-chain fatty acids inhibit the activation of T lymphocytes and myeloid cells and induce innate immune tolerance. | Benef Microbes | 2023 | 38661366 | PubTator, text mining | PubMed |
| Beyond FOXP3: a 20-year journey unravelling human regulatory T-cell heterogeneity. | Front Immunol | 2023 | 38283365 | PubTator, text mining | PubMed |
| Bitter Phytochemicals as Novel Candidates for Skin Disease Treatment. | Curr Issues Mol Biol | 2023 | 38248322 | PubTator, text mining | PubMed |
| Immune cells in the epithelial immune microenvironment of psoriasis: emerging therapeutic targets. | Front Immunol | 2023 | 38239345 | PubTator, text mining | PubMed |
| A comprehensive battery of flow cytometric immunoassays for the in vitro testing of chemical effects in human blood cells. | Front Immunol | 2023 | 38229911 | PubTator, text mining | PubMed |
| GLIS1, Correlated with Immune Infiltrates, Is a Potential Prognostic Biomarker in Prostate Cancer. | Int J Mol Sci | 2023 | 38203661 | PubTator, text mining | PubMed |
| Dysregulation of Lymphatic Endothelial VEGFR3 Signaling in Disease. | Cells | 2023 | 38201272 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2826/papers?page=4